Wellcome Sanger
the Wellcome Sanger Institute-led DtL project aims to sequence all roughly 70,000 eukaryotic species of Britain and Ireland, running one of the world's highest-throughput de novo assembly pipelines.
- Country
- United Kingdom
eu
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ | ✓ |
| ecosystem-restoration | ✓ | ✓ | — | ✓ |
Regulatorsfdaemanmpausda-aphisefsamoa-china
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biodiversity genomics | ecosystem-restoration | Low | → |
| Genomic pathogen surveillance (service) | diagnostics-medtech | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.